[HTML][HTML] Hijacking of the AP-1 signaling pathway during development of ATL
H Gazon, B Barbeau, JM Mesnard… - Frontiers in …, 2018 - frontiersin.org
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a fatal malignancy
known as adult T-cell leukemia (ATL). One way to address the pathology of the disease lies …
known as adult T-cell leukemia (ATL). One way to address the pathology of the disease lies …
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
Cancer management is major concern of health organizations and viral cancers account for
approximately 15.4% of all known human cancers. Due to large number of patients, efficient …
approximately 15.4% of all known human cancers. Due to large number of patients, efficient …
[HTML][HTML] HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases
E Eusebio-Ponce, E Anguita… - Revista Española de …, 2019 - ncbi.nlm.nih.gov
ABSTRACT The Human T-Lymphotropic Virus type 1 (HTLV-1) affects up to 10 million
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …
people worldwide. It is directly associated to one of the most aggressive T cell malignancies …
[HTML][HTML] HTLV-1 infection and adult T-cell leukemia/lymphoma—a tale of two proteins: tax and HBZ
HTLV-1 (Human T-cell lymphotropic virus type 1) is a complex human delta retrovirus that
currently infects 10–20 million people worldwide. While HTLV-1 infection is generally …
currently infects 10–20 million people worldwide. While HTLV-1 infection is generally …
[HTML][HTML] Mechanisms of oncogenesis by HTLV-1 Tax
The human T-cell lymphotropic virus type 1 (HTLV-1) is the etiological agent of adult T-cell
leukemia/lymphoma (ATLL), a neoplasm of CD4+ CD25+ T cells that occurs in 2–5% of …
leukemia/lymphoma (ATLL), a neoplasm of CD4+ CD25+ T cells that occurs in 2–5% of …
Collective infectious units in viruses
R Sanjuán - Trends in microbiology, 2017 - cell.com
Increasing evidence indicates that viruses do not simply propagate as independent virions
among cells, organs, and hosts. Instead, viral spread is often mediated by structures that …
among cells, organs, and hosts. Instead, viral spread is often mediated by structures that …
[HTML][HTML] HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment
N Futsch, R Mahieux, H Dutartre - Viruses, 2017 - mdpi.com
Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …
Tunneling nanotubes as a novel route of cell-to-cell spread of herpesviruses
M Panasiuk, M Rychłowski, N Derewońko… - Journal of …, 2018 - Am Soc Microbiol
Various types of intercellular connections that are essential for communication between cells
are often utilized by pathogens. Recently, a new type of cellular connection, consisting of …
are often utilized by pathogens. Recently, a new type of cellular connection, consisting of …
Recent updates on viral Oncogenesis: Available preventive and therapeutic entities
Human viral oncogenesis is a complex phenomenon and a major contributor to the global
cancer burden. Several recent findings revealed cellular and molecular pathways that …
cancer burden. Several recent findings revealed cellular and molecular pathways that …
[HTML][HTML] CCR4 as a therapeutic target for cancer immunotherapy
O Yoshie - Cancers, 2021 - mdpi.com
Simple Summary CCR4 is a chemokine receptor selectively expressed on normal T cell
subsets such as type 2 helper T cells, skin-homing T cells and regulatory T cells, and on skin …
subsets such as type 2 helper T cells, skin-homing T cells and regulatory T cells, and on skin …